Specifically, rare heterozygous mutations in TREM2, which within the brain is exclusively expressed in microglia cells, dramatically increase the risk for late onset AD in a magnitude similar to ApoE ε4 (Guerreiro et al, 2013; Jonsson et al, 2013). This evidence concerns the gene TREM2 and Alzheimer disease.